Alpha Tau Medical :
DRTS
DRTS
Stock Data
$13.47
$0.08 (0.59%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Alpha Tau Medical Ltd is a pioneering oncology therapeutics company based in Jerusalem, Israel, focused on the development and commercialization of its innovative Alpha DaRT technology. This technology is designed to treat solid tumors in various cancers, including skin, oral, pancreatic, prostate, and breast cancers, through clinical trials. Additionally, Alpha Tau Medical is exploring the potential of Alpha DaRT in preclinical studies for treating brain, liver, glioblastoma multiforme, and lung cancers, aiming to offer new hope in the fight against cancer.
All Alpha Tau Medical Articles
1 Article
No articles found for Alpha Tau Medical.